drugset / Trial / NCT00480532

A Study of Continuous Oral Contraceptives and Doxycycline

NCT00480532

Completed 131 enrolled Oregon Health and Science University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to learn if the study drug, doxycycline, can decrease the amount of unplanned vaginal bleeding that women commonly experience when taking combined oral contraception (COC)- pills with estrogen and progestin - in a continuous fashion - no hormone-free week. The study drug, doxycycline, is an antibiotic used commonly for many conditions (i.e. acne, Chlamydia infections, pneumonia) and can be safely used on a daily basis. Doxycycline has been shown to decrease unplanned vaginal bleeding in progestin-only contraception but has not been studied in combined hormonal contraception.

Timeline

Start
2007-05
Primary completion
2010-01
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 40 mg Oral
Subject Doxycycline Small molecule 100 mg Oral
Background Lybrel Unknown 20 ug Oral
Background Lybrel Unknown 90 ug Oral

Indications

No indication recorded.